Roopal Thakkar
Fortune : 12 M $ au 31/05/2026
Fortune : 12 M $ au 31/05/2026
Roopal Thakkar is currently Chief Scientific Officer, Executive VP-R&D at AbbVie, Inc. since 2024.
Formerly, Dr. Thakkar was Chief Medical Officer & Senior Vice President at Global Therapeutics, Inc. Education includes an undergraduate degree from the University of Michigan and a doctorate from Wayne State University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 06/03/2026 | 55 374 ( 0 % ) | 12 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ABBVIE INC. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
| Sociétés | Poste | Fin |
|---|---|---|
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Commercial Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wayne State University School of Medicine
Wayne State University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national